Mus vs Sao Tome and Principe: Estimated antiretroviral therapy coverage among people living with HIV

Mus
36.0%
in 2025
Sao Tome and Principe
97.0%
in 2025
Mus rank
2nd
Sao Tome and Principe rank
2nd

Estimated antiretroviral therapy coverage among people living with HIV over time

  • Mus
  • Sao Tome and Principe
020406080100200020122025

How they compare

Sao Tome and Principe currently reports 97.0% against 36.0% in Mus, a difference of 61.0%.

That makes Sao Tome and Principe's figure about 2.7 times Mus's.

The two have swapped places 2 times across 26 shared years of data; in 2000 it was Sao Tome and Principe ahead.

Mus ranks 2nd and Sao Tome and Principe ranks 2nd of 2 regions.

Sao Tome and Principe has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Mus Sao Tome and Principe Difference Ahead
2000s 2.9% 3.6% 0.7% Sao Tome and Principe
2010s 20.5% 49.9% 29.4% Sao Tome and Principe
2020s 30.7% 93.3% 62.7% Sao Tome and Principe

Averages of every year both report within each decade.

Frequently asked questions

Which has higher estimated antiretroviral therapy coverage among people living with hiv, Mus or Sao Tome and Principe?
Sao Tome and Principe, at 97.0% against 36.0% in Mus as of 2025.
What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Mus and Sao Tome and Principe?
61.0%, with Sao Tome and Principe ahead.
How many years of comparable data are there for Mus and Sao Tome and Principe?
26 years are reported by both, from 2000 to 2025.
How do Mus and Sao Tome and Principe rank globally for estimated antiretroviral therapy coverage among people living with hiv?
Mus ranks 2nd and Sao Tome and Principe ranks 2nd of 2 regions.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Mus vs Sao Tome and Principe: Estimated antiretroviral therapy coverage among people living with HIV. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/compare/estimated-antiretroviral-therapy-coverage-among-people-living-with-hiv-percent/mus-2/sao-tome-and-principe/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/estimated-antiretroviral-therapy-coverage-among-people-living-with-hiv-percent/mus-2/sao-tome-and-principe/">Mus vs Sao Tome and Principe: Estimated antiretroviral therapy coverage among people living with HIV</a> — Statizoid

About this data

Indicator
Estimated antiretroviral therapy coverage among people living with HIV (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
158 places, 4,029 data points, 2000–2025
Last refreshed